Prof. Alaa Kandil

Alexandria School of Medicine, Egypt

Full professor

Email: alaakandil@hotmail.com

Qualifications

1992 Ph.D., Alexandria School of Medicine, Egypt

1986 M.Sc., Alexandria University Hospitals, Egypt

Publications (Selected)

1. Khalid AlSaleh, Heba Al Zahwahry, Adda Bounedjar, Mohammed Oukkal, Ahmed Saadeddine, Hassen Mahfouf, Kamel Bouzid, Assia Bensalem, Taha Filali, Hikmat Abdel-Razeq, Blaha Larbaoui, Alaa Kandil, Omalkhair Abulkhair, Meteb Al Foheidi, Hassan Errihani, Marwan Ghosn, Nashwa Abdel-Aziz, Maria Arafah, Hamouda Boussen, Farida Dabouz, Haleem Rasool , Mohun Bahadoor, Jihen Ayari, Sharif Kullab, and Jean-Marc Nabholtz, (2021) "Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial", JCO Global Oncology, Vol. 7, p. 811-819.
2. Hesham Elghazaly, Hope S. Rugo, Hamdy A. Azim, Sandra M. Swain, Banu Arun,Matti Aapro, Edith A. Perez, Benjamin O. Anderson, Frederique Penault-Llorca, Pierfranco Conte, Nagi S. El Saghir, Cheng-Har Yip, Marwan Ghosn, Philip Poortmans, Mohamed A. Shehata, Armando E. Giuliano, Jessica W. T. Leung, Valentina Guarneri, Joseph Gligorov, Bahadir M. Gulluoglu, Hany Abdel Aziz, Mona Frolova, Mohamed Sabry, Charles M. Balch, Roberto Orecchia, Heba M. El-Zawahry, Sana Al-Sukhun, Khaled Abdel Karim, Alaa Kandil, Ruslan M. Paltuev, Meteb Foheidi, Mohamed El-Shinawi, Manal ElMahdy, Omalkhair Abulkhair, Wentao Yang, Adel T. Aref, Joaira Bakkach, Nermean Bahie Eldin and Hagar Elghazawy, (2021) "Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer", Cancers, 13(9), 2262.
3. Mohammed M. Rizk, Alaa E. Kandil, Suzan M. Helal, Waleed G. Elshazly, Doreen N. Younan, Eman Z. Elkemary, (2020) "TFAP2E and MLH1 Genes Methylation Pattern and Microsatellite Instability as Predictors of Rectal Cancer Response to Neoadjuvant Chemoradiotherapy", Research in Oncology, Vol. 16, No. 2: 56-65.
4. K. Alsaleh, A. Bounedjar, M. Oukkal, A. Saadeddine, H. Al Zahwahry, H. Mahfouf, K. Bouzid, A. Bensalem, T. Fillali, H. Abdel-Razek, B. Larbaoui, A. Kandil, M. Al Foheidi, H. Errihani, M. Ghosn, N. Abdel-Aziz, F. Dabouz, K. Bahadoor, S. Kullab, J.M. Nabholtz on behalf of the International Cancer Research Group (ICRG), King Saud University Medical City, Riyadh, Saudi Arabia, (2020) "Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront Oncotype Dx recurrence score (RS) – Results from the SAFIA Phase III trial", ICRG1201- SAFIA STUDY ASCO ABSTARCT 2020, Abstract no. 315105.
5. Alaa Kandil, Mohamed Yousry Gouda, Mohamed Sabry El-Kady, Mounir Zaki, Dalia Hatem, (2020) "Docetaxel (Taxotere®) Combined Regimens in Early Stage Breast Cancer (Adjuvant and Neoadjuvant), Glimpses from the "Real World" Practice in Egypt", Pan Arab Journal of Oncology.13 (1).
6. J. -M. Nabholtz, K. Al Saleh, A.Bounedjar, H. Abdel-Razeq, H. Errihani, A. Saadeddin, M. Al Foheidi, M. Ghosn, H. El Zawahry, A. Kandil, N. Abdel-Aziz, F. Dabouz, S. Kullab, (2018) "232TiP - A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)", Annals of Oncology, Volume 29, Supplement 8, Page viii85.
7. Asmaa Nazeer, Alaa Kandil, Omar Zahra, Maher Soliman, (2017) "Clinicopathological Features and Treatment Outcomes in Ewing's Sarcoma Patients: A 10-year experience of Alexandria Clinical Oncology Department", Indian J Med Paediatr Oncol. 38(3): 316-320.
8. Ibrahim F. Kharbousha, Hanaa M. Ismaila, Alaa A. Kandil, Heba M. Mamdouha, Yasmine Y. Muhammada, Omnia G. El Sharkawya Hassan N. Sallama, (2011) "Raising the Breast Health Awareness amongst Women in an Urban Slum Area in Alexandria, Egypt", Breast Care, 6: 375–379.
9. Abdelaziz OS, Kandil A, El-Assaal S, Abdelaziz A, Rostom Y, Rashed Y, (2011) "Linear accelerator-based stereotactic radiosurgery of intracranial meningiomas: results of the first 5 years of clinical practice", Neurosurg Rev. 34(1): 87-99.
10. ES ElAlfy, A Kandil, SI Zaki, YM ElKerm, (2010) "Impact of adjuvant chemotherapy on survival of patients with stage II colon cancer, retrospective study", Abstract 3368, ESMO, Milan, Italy.
11. Mohamed Meshref, Samir Shehata, Ebtesam Saad, Salah Elmesidi, Yousri Goda, Hanaa Koheil, Heba Elzawahri, Alaa Kandil, Thoraya Abdelhamid, Mounir Zaki, (2010) "A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer", Hematology/Oncology Journal, Vol. 3, No. 1.
12. D. M. Abdalla, M. A. Hamza, A. E. , Kandil, L. K,Younes, A. F. Sorrour, (2009), "MYCN gene amplification and DNA ploidy in peripheral neuroblastic tumors", J Clin Oncol 27, (suppl; abstr e22123).